The Advent of Personalized Medicine

New discoveries and venture capital investments in the bioscience industry are occurring at a breathtaking pace and have led to the emergence of “personalized medicine” which recognizes the need for tailored treatments. From genome sequencing to CAR T-Cell therapy, scientific medical discoveries are having a significant impact on the human condition and their influence will continue to grow in the future. All of this means the bioscience industry is ripe with potential, and the depth and breadth of current and future opportunities, both known and unknown, support the fact that biotechnology should be a core piece of an investment portfolio.